Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials

BACKGROUND: Obesity is a major health concern for breast cancer survivors, being associated with high recurrence and reduced efficacy during cancer treatment. Metformin treatment is associated with reduced breast cancer incidence, recurrence and mortality. To better understand the underlying mechani...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellerba, Federica, Chatziioannou, Anastasia Chrysovalantou, Jasbi, Paniz, Robinot, Nivonirina, Keski-Rahkonen, Pekka, Trolat, Amarine, Vozar, Béatrice, Hartman, Sheri J., Scalbert, Augustin, Bonanni, Bernardo, Johansson, Harriet, Sears, Dorothy D., Gandini, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798585/
https://www.ncbi.nlm.nih.gov/pubmed/36581893
http://dx.doi.org/10.1186/s12967-022-03809-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798585/
https://www.ncbi.nlm.nih.gov/pubmed/36581893
http://dx.doi.org/10.1186/s12967-022-03809-6

Ejemplares similares